Neurology

Building Your Care Team and Long-Term Monitoring

At a Glance

Managing LGMDR1 requires a multidisciplinary care team led by a neuromuscular specialist. Regular monitoring of breathing and physical function is essential. Patients must also carry an anesthesia precaution letter, as certain anesthetics can cause severe muscle breakdown.

Managing LGMDR1 effectively requires more than just one doctor. Because this condition affects your physical function and can impact your breathing, a multidisciplinary care team is the standard of care ^[1]^[2]. This team works together to monitor your health and maintain your quality of life.

Your core team should include:

Neuromuscular Specialist: Typically a neurologist with expertise in muscular dystrophies who serves as your primary guide for the disease ^[3].
Physical Therapist (PT): A PT helps you maintain mobility and manage joint contractures through specialized, non-damaging exercises ^[4]^[5].
Pulmonologist: A breathing specialist is essential for monitoring the health of your respiratory muscles ^[6].
Cardiologist: While heart issues are rare in LGMDR1, having a baseline evaluation and occasional check-ups is a standard safety measure ^[7]^[8].
Occupational Therapist (OT): An OT helps you adapt your home and work environment, ensuring safety and helping to conserve energy ^[9].

Long-Term Monitoring: A Surveillance Schedule

Because LGMDR1 is a progressive condition, regular “check-ins” are necessary to catch changes early—especially in your breathing.

Area of Health	Monitoring Tool	Recommended Frequency
Respiratory	Pulmonary Function Tests (PFTs), including FVC (Forced Vital Capacity) in both sitting and lying down positions ^[6]^[10].	Typically every 6–12 months, or sooner if you notice new symptoms like morning headaches or sleepiness ^[6]^[11].
Cardiac	EKG (heart rhythm) and Echocardiogram (heart structure) ^[7].	Baseline at diagnosis; then every 2–5 years unless clinical symptoms appear ^[7]^[8].
Mobility	Physical Therapy Assessment using tools like the NSAD (North Star Assessment) to track muscle strength ^[12].	Every 6–12 months ^[12].
Bone Health	DEXA Scan to check bone density, especially if mobility decreases.	As recommended by your specialist. Crucial if you were ever misdiagnosed and prescribed corticosteroids, which can cause rapid bone loss ^[13].

Quality of Life and Respiratory Support

As your muscles weaken, your quality of life can be significantly improved by using the right tools at the right time.

Breathing Support: If your PFTs show that your breathing muscles are working harder, your doctor may recommend Non-Invasive Ventilation (NIV), such as a BiPAP machine ^[14]. This is often used only at night to help you get more restful sleep and keep your oxygen levels steady ^[15]^[16].
Mobility Aids: Using a cane, walker, or wheelchair is not a sign of “giving up.” Instead, these tools are designed to help you save energy, prevent falls, and stay active in your community for as long as possible. Working with an Occupational Therapist or Physical Medicine specialist is crucial for ensuring these devices are fitted properly, safe to use, and covered by insurance ^[9].
Mental Health: Living with a chronic condition can be emotionally taxing. Many patients find that counseling or connecting with patient advocacy groups (such as the Coalition to Cure Calpain 3) is vital for managing the stress that can sometimes accompany a progressive diagnosis ^[17].

A Critical Note on Surgery and Anesthesia

If you ever require surgery or emergency care, it is absolutely critical to tell your surgical team and anesthesiologist that you have LGMDR1 (muscular dystrophy). Due to how the condition affects muscle fibers, you must explicitly avoid depolarizing muscle relaxants (such as succinylcholine) and inhaled/volatile anesthetic gases ^[18]^[19]. The use of these specific anesthetics can trigger life-threatening complications like extreme muscle breakdown (rhabdomyolysis) and dangerous potassium spikes.

Your neuromuscular specialist can provide you with a standardized “anesthesia precaution” letter detailing these exact restrictions to keep in your medical files and wallet ^[18].

Common questions in this guide

Which specialists should be on my LGMDR1 care team?

Your core team should include a neuromuscular specialist, a physical therapist, a pulmonologist, a cardiologist, and an occupational therapist. They work together to monitor your health and maintain your mobility and breathing.

How often do I need pulmonary function tests (PFTs) with LGMDR1?

You should generally have pulmonary function tests every 6 to 12 months. It is important that these tests measure your breathing capacity while you are both sitting up and lying down to accurately assess respiratory muscle strength.

Are heart problems common in LGMDR1?

Heart issues are rare in LGMDR1, but regular monitoring is still standard for safety. You should have a baseline EKG and echocardiogram at diagnosis, followed by check-ups every 2 to 5 years unless symptoms appear.

Why do I need special precautions for anesthesia with LGMDR1?

Certain anesthetics and muscle relaxants can trigger life-threatening complications like severe muscle breakdown, known as rhabdomyolysis. Always inform your surgical team about your condition and provide an anesthesia precaution letter from your specialist.

When is a BiPAP machine recommended for LGMDR1?

A BiPAP machine or non-invasive ventilation is recommended when breathing tests show your respiratory muscles are working harder. It is typically used at night to improve sleep quality and maintain steady oxygen levels.

Curated prompts to bring to your next appointment.

1.Who will serve as the lead coordinator for my multidisciplinary care team?
2.When should I have my next pulmonary function test (PFT), and can you ensure it includes measurements while I am lying down (supine)?
3.Even though cardiac issues are rare in LGMDR1, how often do you recommend I get an EKG or echocardiogram?
4.Can you provide me with an 'anesthesia protocol' or letter to keep in my records in case I ever need surgery?
5.Are there specific mental health professionals who specialize in supporting patients with chronic, progressive conditions like muscular dystrophy?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (19)

1
Limb Girdle Muscular Dystrophies.
Bockhorst J, Wicklund M
Neurologic clinics 2020; (38(3)):493-504 doi:10.1016/j.ncl.2020.03.009.
PMID: 32703463
2
Natural history of LGMD2A for delineating outcome measures in clinical trials.
Richard I, Hogrel JY, Stockholm D, et al.
Annals of clinical and translational neurology 2016; (3(4)):248-65 doi:10.1002/acn3.287.
PMID: 27081656
3
Disease Progression and Mutation Pattern in a Large Cohort of LGMD R1/LGMD 2A Patients from India.
Ganaraja VH, Polavarapu K, Bardhan M, et al.
Global medical genetics 2022; (9(1)):34-41 doi:10.1055/s-0041-1736567.
PMID: 35169782
4
Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages.
Siciliano G, Simoncini C, Giannotti S, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2015; (34(1)):3-8.
PMID: 26155063
5
Clinical and Pathological Heterogeneity of Korean Patients with CAPN3 Mutations.
Park HJ, Jang H, Lee JH, et al.
Yonsei medical journal 2016; (57(1)):173-9 doi:10.3349/ymj.2016.57.1.173.
PMID: 26632398
6
[Update on the respiratory management of patients with chronic neuromuscular disease].
Priou P, Trzepizur W, Meslier N, Gagnadoux F
Revue de pneumologie clinique 2017; (73(6)):316-322 doi:10.1016/j.pneumo.2017.10.001.
PMID: 29174288
7
Cardiopulmonary dysfunction in patients with limb-girdle muscular dystrophy 2A.
Mori-Yoshimura M, Segawa K, Minami N, et al.
Muscle & nerve 2017; (55(4)):465-469 doi:10.1002/mus.25369.
PMID: 27500519
8
Evaluation of heart involvement in calpainopathy (LGMD2A) using cardiovascular magnetic resonance.
Quick S, Schaefer J, Waessnig N, et al.
Muscle & nerve 2015; (52(4)):661-3 doi:10.1002/mus.24717.
PMID: 26032656
9
Current and Future Therapeutic Strategies for Limb Girdle Muscular Dystrophy Type R1: Clinical and Experimental Approaches.
Şahin İO, Özkul Y, Dündar M
Pathophysiology : the official journal of the International Society for Pathophysiology 2021; (28(2)):238-249 doi:10.3390/pathophysiology28020016.
PMID: 35366260
10
Unveiling the Respiratory Muscle Strength in Duchenne Muscular Dystrophy: The Impact of Nutrition and Thoracic Deformities, Beyond Spirometry.
Yuksel Kalyoncu M, Gokdemir Y, Yilmaz Yegit C, et al.
Children (Basel, Switzerland) 2024; (11(8)) doi:10.3390/children11080994.
PMID: 39201929
11
Pulmonary Dysfunction in Children with Dystrophinopathy: A Cross-Sectional Study.
Meena AK, Kamila G, Anand V, et al.
Indian journal of pediatrics 2025; (92(12)):1283-1288 doi:10.1007/s12098-024-05368-8.
PMID: 39804450
12
Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies.
James MK, Alfano LN, Muni-Lofra R, et al.
Physical therapy 2022; (102(10)) doi:10.1093/ptj/pzac113.
PMID: 35932452
13
Experiences in the molecular genetic and histopathological evaluation of calpainopathies.
Ozyilmaz B, Kirbiyik O, Ozdemir TR, et al.
Neurogenetics 2022; (23(2)):103-114 doi:10.1007/s10048-022-00687-4.
PMID: 35157181
14
Successful bilevel positive airway pressure therapy in a patient with amyotrophic lateral sclerosis after emergency laparotomy: A case report.
Koyama Y, Tsuzaki K, Shimizu H, et al.
Saudi journal of anaesthesia 2020; (14(4)):538-540 doi:10.4103/sja.SJA_375_20.
PMID: 33447203
15
A novel CAPN3 mutation in late-onset limb-girdle muscular dystrophy with early respiratory insufficiency.
Martinez-Thompson JM, Moore SA, Liewluck T
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2018; (53()):229-231 doi:10.1016/j.jocn.2018.04.025.
PMID: 29685414
16
Epidemiology and natural history in 101 subjects with FKRP-related limb-girdle muscular dystrophy R9. The Norwegian LGMDR9 cohort study (2020).
Jensen SM, Müller KI, Mellgren SI, et al.
Neuromuscular disorders : NMD 2023; (33(2)):119-132 doi:10.1016/j.nmd.2022.11.005.
PMID: 36522254
17
Psychological parameters impact health-related quality of life in mental and physical domains in adults with muscular dystrophy.
O'Dowd DN, Bostock EL, Smith D, et al.
Neuromuscular disorders : NMD 2021; (31(4)):328-335 doi:10.1016/j.nmd.2021.01.007.
PMID: 33593658
18
Limb-girdle muscular dystrophy in pregnancy: a narrative review.
Ahmed HS
Archives of gynecology and obstetrics 2024; (310(5)):2373-2386 doi:10.1007/s00404-024-07738-1.
PMID: 39285011
19
Trigger-Free Neuraxial Anaesthesia for Emergency Evacuation of Retained Products of Conception in Limb-Girdle Muscular Dystrophy: A Case Report and Literature Review.
AlAamer R, Alanzi A, Alatefi D, Alselaiti AA
Cureus 2025; (17(10)):e95759 doi:10.7759/cureus.95759.
PMID: 41322769

This page provides educational information on building an LGMDR1 care team and monitoring protocol. Always consult your neuromuscular specialist for personalized medical advice and specific anesthesia precautions.

Get notified when new evidence is published on Calpain-3-related limb-girdle muscular dystrophy R1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents